Global Media Strategies -- Your Brand, Your Audience

Inspire announces presentations at European Cystic Fibrosis Society annual meeting

June 12, 2009 By: NCTechNews Category: Pharmaceuticals

(Durham, N.C.) Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today Inspire scientists and collaborators are presenting additional data from TIGER-1, the Company’s first Phase 3 trial with denufosol tetrasodium for the treatment of cystic fibrosis, at the European Cystic Fibrosis Society annual meeting June 10 - 13, 2009 in Brest, France.

The oral poster presentation, “Effects of Denufosol on Sinusitis-related Complaints in a Phase 3 Trial in Cystic Fibrosis Patients” (A.R. Mospan, T.A. Durham, A.E. Schaberg, F.J. Accurso), occurs during Oral Poster Session II - Clinical Care on Thursday, June 11, 2009 from 4:30 - 6:00 PM (local time).

The oral presentation, “Relationship between Pulmonary Exacerbations and Lung Function Decline in a Six Month Trial of Denufosol” (F.J. Accurso, T.A. Durham, A.E. Schaberg), occurs during Workshop 17 - Clinical Trials in CF Lung Disease on Friday, June 12, 2009 from 4:30 - 6:00 PM (local time).

Inspire is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspire’s goal is to build and commercialize a sustainable portfolio of innovative new products based on its technical and scientific expertise. The most advanced compounds in Inspire’s clinical pipeline are Prolacria™ for dry eye and denufosol tetrasodium for cystic fibrosis, which are both in Phase 3 development, and AzaSite® for blepharitis, which is in Phase 2 development. Inspire receives revenues related to the promotion of AzaSite for bacterial conjunctivitis, the co-promotion of Elestat® for allergic conjunctivitis and royalties based on net sales of Restasis® for dry eye. For more information, visit www.inspirepharm.com.

Comments are closed.

← Clean and green DesignLine hybrid bus rolls into service in Baltimore
Tech Werks releases new features at InfoComm09 →

  • Controlling Quality
    An RTP firm is gaining international notoriety as a leader in analytical instrumentation for the pharmaceutical and chemical manufacturing industries, sharing innovative solutions to evolving pharmaceutical and chemical manufacturing challenges, presenting on emerging multi-variant approaches to obtaining immediate, unambiguous results from drug product samples at a recent major international tradeshow.

    Portable Power
    Alternative energy solutions provider INI Power Systems, Inc. recently marked its ten-year anniversary by unveiling the innovative new Trinity™ series of portable alternative energy hybrid solutions at two major events catering to the defense and emergency first responder marketplaces, with attendees searching for reliable, flexible power systems with multiple applications.

    EV Innovation
    Morrisville-based green transportation pioneer Evatran™ recently hosted a demonstration of its Plugless Power™ hands-free electric vehicle (EV) charging system, showcasing cost savings and convenience of EV usage in residential, commercial and public applications.

    guide to success
    Entrepreneurs now have a workbook to guide them through successful implementation of business building blocks thanks to a new goal-setting toolkit for personal and professional success available at no charge from a Cary-based international strategic business consultant.

    Packaging Cures
    RTP-based advertising and branding firm The Marketing Machine helped overcome the issue of illiteracy among medical patients in Ghana, South Africa in designing packaging for the only manufacturer of anti-retroviral drugs in the region, creating individual icons and colors to help patients understand which drugs they needed, regardless of their ability to read.

    Broadband Stimulus
    Two grants funded by the American Recovery and Reinvestment Act are being used by MCNC to expand broadband connectivity and services throughout North Carolina and create more than 1,000 engineering and construction jobs, the organization said.

  • Recent Headlines

















free web site traffic and promotion